Metabolic syndrome in non-obese Taiwanese: New definition of metabolically obese, normal-weight individual

Chinese Medical Journal

Volumn 122, Issue 21, 2009, Pages 2534-2539

  Tsai, Chung Huang ^a,b  

^a CHAOYANG UNIVERSITY OF TECHNOLOGY   (Taiwan)

^b HUNGKUANG UNIVERSITY   (Taiwan)

Author keywords

Body mass index; Metabolically obese, normal weight; Obese

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; HEMOGLOBIN; HEPATITIS B SURFACE ANTIGEN; URIC ACID;

ADULT; AGE DISTRIBUTION; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BETEL NUT; BIOCHEMISTRY; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ERYTHROCYTE COUNT; FEMALE; HEPATITIS C VIRUS; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MASTICATION; MEDICAL EXAMINATION; MEDICAL SOCIETY; METABOLIC SYNDROME X; OBESITY; PHYSICIAN; PREVALENCE; RISK; SMOKING; TAIWAN; THROMBOCYTE COUNT; WAIST CIRCUMFERENCE;

ADULT; AGED; BODY MASS INDEX; BODY WEIGHT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; OVERWEIGHT; RISK FACTORS; TAIWAN;

EID: 73449084839     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.21.003     Document Type: Article

References (32)

1. Amos AF, McCarty DJ, Zimmet P. The rising global of diabetes and its complication: estimates and projections to the year 2010. Diabet Med 1997; 14 Supple 5: s1-s85.
2. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414-1431.
3. Uusitupa M. Lifestyles matter in the prevention of type 2 diabetes. Diabetes Care 2002; 25: 1650-1651.
4. Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S. The metabolically obese, normal-weight individual revisited. Diabetes 1998; 47: 699-713.
5. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 1992; 41: 715-722.
6. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-689.
7. Trevisan M, Liu J, Bahsas FB, Menotti A. Syndrome X and mortality: a population-based study. Risk Factor and Life Expectancy Research Group. Am J Epidemiol 1998; 148: 958-966.
8. Fletcher B, Lamendola C. Insulin resistance syndrome. J Cardiovasc Nurs 2004; 19: 339-345.
9. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-787.
10. Haffner SM, Howard G, Mayer E, Bergman RN, Savage PJ, Rewers M, et al. Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study. Diabetes 1997; 46: 63-69.
11. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Executive summary. Cardiol Rev 2005; 13: 322-327.
12. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome £ a new worldwide definition. Lancet 2005; 366: 1059-1062.
13. Ruderman NB, Schneider SH, Berchtold P. The "metabolically- obese", normal-weight individual. Am J Clin Nutr 1981; 34: 1617-1621.
14. Abraham S, Collins G, Nordsieck M. Relation of childhood weight status to morbidity in adults. HSMHA Health Reports 1971; 86: 273-284.
15. St-Onge MP, Janssen I, Heymsfield SB. Metabolic syndrome in normal-weight Americans: new definition of the metabolically obese, normal-weight individual. Diabetes Care 2004; 27: 2222-2228.
16. Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 2008; 168: 1617-1624.
17. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
18. Lin CC, Liu CS, Lai MM, Li CI, Chen CC, Chang PC, et al. Metabolic syndrome in a Taiwanese metropolitan adult population. BMC Public Health 2007; 7: 239.
19. Grundy SM. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol 1999; 83: 25F-29F.
20. Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 2004; 24: e13-e18.
21. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-359.
22. Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am 2004; 33: 351-375.
23. Li WJ, Xue H, Sun K, Song XD, Wang YB, Zhen YS, et al. Cardiovascular risk and prevalence of metabolic syndrome by differing criteria. Chin Med J 2008; 121: 1532-1536.
24. Tan CE, Ma S, Wai D, Chew SK, Tai ES. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 2004; 27: 1182-1186.
25. Oh JY, Hong YS, Sung YA, Barrett-connor E. Prevalence and factor analysis of metabolic syndrome in an urban Korean population. Diabetes Care 2004; 27: 2027-2032.
26. Gu D, Reynolds K, Wu X, Chen J, Duan X, Reynolds RF, et al. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 2005; 365: 1398-1405.
27. Oh SW, Yoon YS, Lee ES, Kim WK, Park C, Lee S, et al. Association between cigarette smoking and metabolic syndrome: The Korea National Health and Nutrition Examination Survey. Diabetes Care 2005; 28: 2064-2066.
28. Lim S, Park KS, Lee HK, Cho SI; Korean National Health and Nutrition Examination Surveys. Changes in the characteristics of metabolic syndrome in Korea over the period 1998-2001 as determined by Korean National Health and Nutrition Examination Surveys. Diabetes Care 2005; 28: 1810-1812.
29. Schurgin S, Siegel RD. Pharmacotherapy of obesity: an update. Nutr Clin Care 2003; 6: 27-37.
30. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001; 50: 1844-1850.
31. Tsai CH, Li TC, Lin CC. Metabolic syndrome as a risk factor for nonalcoholic fatty liver disease. South Med J 2008; 101: 900-905.
32. Hanley AJ, Williams K, Festa A, Wagenknecht LE, D'Agostino RB Jr, Kempf J, et al. Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 2004; 53: 2623-2633.